Showing 161 - 180 results of 147,064 for search '(( 5 ((non decrease) OR (mean decrease)) ) OR ( 10 ((ng decrease) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166

    Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

    Published 2021
    “…(A-B) GCase levels as assessed by the CBE/4-MU method are significantly decreased in the het <i>GBA1</i> D409V KI mice at 5 months of age in both brain (A) and liver (B). …”
  7. 167

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

    Published 2019
    “…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”
  8. 168
  9. 169
  10. 170

    Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

    Published 2022
    “…<b>(D)</b> The number of recent transposon insertions [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010345#pgen.1010345.ref022" target="_blank">22</a>] as a function of <i>NRPE1’</i> genotype and the number of mCHG-decreasing alleles. …”
  11. 171
  12. 172

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…Similarly, BACE1, LAMP1 and LC3B-II/ LC3B-I were also increased in nimodipine-treated 5XFAD compared to nimodipine treated non-transgenic mice, indicating that nimodipine did not decrease the accumulation of these dystrophic neurite marker proteins. …”
  13. 173
  14. 174
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180